SODIUM SULFACETAMIDE, SULFUR

Manufacturer
Aspen Medical LLC
Effective date
2025-12-15
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 21:56:28

Label at a glance#

ProductSODIUM SULFACETAMIDE, SULFUR
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure16 sections

Storage and handling

Store at 20°C to 25°C (68°F to 77°F). See USP controlled room temperature. Protect from freezing. In case of accidental ingestion contact a Poison Controll Center immediately. Keep container tightly closed. You may report side effects by calling the FDA at 1-800-FDA-1088

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

FOR EXTERNAL USE ONLY. NOT FOR INTRA VAGINAL OR OPHTHALMIC USE. (KEEP AWAY FROM EYES)

INACTIVE INGREDIENT SECTION

Aloe Vera Leaf Extract, Butylated Hydroxytoluene, Cetyl Alcohol, Citric Acid, Cocamidopropyl Betaine, Disodium EDTA, Glycerin, Glyceryl Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium Laureth Sulfate, Sodium Thiosulfate, Stearyl Alcohol, Triacetin, Xanthan Gum.

INDICATIONS & USAGE SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is indicated in the topical control of acne vulgaris, acne rosacea seborrheic dermatitis.

CAUTION

USER SAFETY WARNINGS SECTION

If redness or irritation occurs, discontinue use.

Call your doctor for medial advice about side effect.

DOSAGE & ADMINISTRATION SECTION

Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and leberally apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full leather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing cleanser off sooner or using less often.

FOR EXTERNAL USE ONLY. NOT FOR INTRAVAGINAL OR OPTHALMIC USE. (KEEP AWAY FROM EYES).

KEEP OUT OF REACH OF CHILDREN

(Shake well before use)

STORAGE AND HANDLING SECTION

Store at 20°C to 25°C (68°F to 77°F). See USP controlled room temperature. Protect from freezing.

In case of accidental ingestion contact a Poison Controll Center immediately. Keep container tightly closed.

You may report side effects by calling the FDA at 1-800-FDA-1088

DESCRIPTION SECTION

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl)sulfonyl]-acetamide monosodium salt, monohydrate. The structural formula is:

StructureStructure

CLINICAL PHARMACOLOGY SECTION

The most widely accepted mechanism of action of sulfonamides is the woods-fields theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (FABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological halflife has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is unknown but it has been reported that it inhibits the growth of propionibacterium acnes andthe formation of free fatty acids.

CONTRAINDICATIONS SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is not to be used by patients with kidney disease.

WARNINGS SECTION

Although it is rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

GENERAL

PRECAUTIONS SECTION

If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

INFORMATION FOR PATIENTS

INFORMATION FOR PATIENTS SECTION

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY Category C

PREGNANCY SECTION

Animal reproduction studies have not been conducted with Sodium Sulfacetamide 10% & Sulfur 5% Cleanser. It is also not known whether Sodium Sulfacetamide 10% & Sulfur 5% Cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Sulfacetamide 10% & Sulfur 5% Cleanser should be given to a pregnant woman only if clearly needed.

PEDIATRIC USE

PEDIATRIC USE SECTION

Safety and effectiveness in children under the age of 12 have not been established.

NURSING MOTHERS

NURSING MOTHERS SECTION

It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sodium Sulfacetamide 10% & Sulfur 5% Cleanser. However, small amounts of orally administered sulfonamides have milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is administered to a nursing woman.

ADVERSE REACTIONS SECTION

Although rare, sodium sulfacetamide may cause local irritation.

HOW SUPPLIED SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is available in

6 oz (170 g) bottle NDC 87026-202-06

12 oz (340 g) bottle NDC 87026-202-12

SPL UNCLASSIFIED SECTION

This bottle is not filled to the top but does contain 6 oz of of product as identified on the front panel of the bottle.

SPL UNCLASSIFIED SECTION

USA Manufactured For:

Aspen Medical LLC

8 The Green Ste. B

Dover, DE 19901

Rev. 10/25

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Aspen Medical

NDC 87026-202-06

Rx Only

Sodium

Sulfacetamide

& Sulfur

Sodium Sulfacetamide 10%

Sulfur 5%

10%/5%

Cleanser

For External Use only

NET WT. 6 OZ. (170 g)

LabelLabel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapPSN1
999613sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Medicated Liquid SoapSCD1
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapSY1
999613sulfacetamide sodium 10 % / sulfur 5 % Topical CleanserSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130387026202060GTIN-13: 0387026202060
EAN-13: 0387026202060
GTIN-12: 387026202060
UPC-A: 387026202060
GTIN storage (14 digits): 00387026202060
SS10S5_6oz_jpg.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87026-202-06SODIUM SULFACETAMIDE, SULFUR170 g in 1 BOTTLELIQUID1701
87026-202-12SODIUM SULFACETAMIDE, SULFUR340 g in 1 BOTTLELIQUID3401

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87026-20287026-202-06, 87026-202-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SODIUM SULFACETAMIDE, SULFURSODIUM SULFACETAMIDE 10%, SULFUR 5%Aspen Medical LLC46064e69-cc19-8cee-e063-6394a90a8d322025-12-15Warnings, Adverse reactionsExact identifier
ndc (package): 87026-202-12
ndc (package): 87026-202-06
ndc (product): 87026-202
ndc11 (package): 87026020206
ndc11 (package): 87026020212
spl id: 46064e69-cc1a-8cee-e063-6394a90a8d32
spl set id: 46064e69-cc19-8cee-e063-6394a90a8d32

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.